Fortress Biotech, Inc. (FBIO) stock
FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
$1.82+0.11 (+6.43%)
Close on Nov 17, 2026Market cap $66.94MP/E –Yield –
Fortress Biotech pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Fortress Biotech's pe ratio was 0.6× on Nov 11, 2026, against 21.9× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −27.9 |
| 2025 | Dec 31, 2025 | 28.5× | – |
See a number that looks wrong?